Pharmaceutical IT Spending Forecast in the US to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Hayat Pharmaceutical Industries Co PSC

Hayat Pharmaceutical Industries Co PSC

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Hayat Pharmaceutical Industries Co PSC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Cairo Pharmaceuticals & Chem. Industries

Cairo Pharmaceuticals & Chem. Industries

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Cairo Pharmaceuticals & Chem. Industries compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

United States Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

United States Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 122 pages

BMI View: The US pharmaceutical industry is under increasing pressure. The faltering economy and precarious fiscal situation mean the government has fewer funds for healthcare programmes such as Medicaid – a scheme for those on low incomes. Suppressed consumer spending will also negatively affect the ...

Industries: Drug and Medication | Countries: United States

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

  • $ 1 500
  • Industry report
  • by Mordor Intelligence LLP
  • September 2014

Growing numbers of farm and companion animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare. Food safety concerns have boosted the usage of vaccines for better farm animal production. The ...

Industries: Drug and Medication | Countries: World, France, Europe, Canada, Germany, North America, United States, India, China, Switzerland, Brazil, Mexico, Sweden, Spain, Italy, Japan

Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

  • $ 1 500
  • Industry report
  • by Mordor Intelligence LLP
  • September 2014

Global market for veterinary anti-infectives is estimated to be worth $4.37 billion in 2014. Expected to grow at a healthy CAGR of 8.5%, the market is set to reach $6.92 billion by 2019. For the past several decades, the veterinary health business units have been able to take advantage of antibiotics ...

Industries: Drug and Medication | Countries: World, France, Canada, Germany, Europe, United States, North America, Switzerland, Mexico, Sweden, Spain, Italy, Japan, India, China

U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for U.S. Physical Therapy, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: United States

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2014

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 98 pages

Includes 3 FREE quarterly updates BMI View: Puerto Rico will continue to attract investment from multinational pharmaceutical companies due to its tax incentives, relatively low production costs and close ties with the US economy. Drugmakers can also capitalise on the government's promotion of the local ...

Industries: Drug and Medication | Countries: United States

Dystonia - Pipeline Review, H2 2014

Dystonia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 41 pages

Dystonia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Dystonia - Pipeline Review, H2 2014', provides an overview of the Dystonia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dystonia, complete with comparative analysis at ...

Industries: Drug Discovery and Development | Countries: World, United States

Iron Deficiency Anemia - Pipeline Review, H2 2014

Iron Deficiency Anemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 60 pages

Iron Deficiency Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Iron Deficiency Anemia - Pipeline Review, H2 2014', provides an overview of the Iron Deficiency Anemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Iron Deficiency ...

Industries: Pathology | Countries: United States

Burkitt Lymphoma - Pipeline Review, H2 2014

Burkitt Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 47 pages

Burkitt Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Burkitt Lymphoma - Pipeline Review, H2 2014', provides an overview of the Burkitt Lymphoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete ...

Industries: Pathology | Countries: United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.